オハイオにおけるうつ病の臨床試験
オハイオ内の拠点で、うつ病に関する26件の研究が参加者を募集しています。
オハイオ内の都市
公式研究テキスト（英語）
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Cleveland Clinic, Cleveland
- The Ohio State University, Department of Psychiatry, Columbus
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/15更新 · NCT07002034A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Independence
- Seaport Investigator Site, North Canton
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/09/14更新 · NCT07065240A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Insight Clinical Trials, Independence
被験者募集中第3相
18歳〜74歳 · 全性別 · 2026/09/08更新 · NCT07076407A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, Columbus
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/02更新 · NCT07610473NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Mason
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/11更新 · NCT06911112E-Mindfulness Approaches for Living After Breast Cancer
- Indu and Raj Soin Medical Center, Beavercreek
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- Ohio State University Comprehensive Cancer Center, Columbus
- 他16件
被験者募集中第3相
18歳〜50歳 · 全性別 · 2026/08/04更新 · NCT06748222Modulating Spinal Interoceptive Pathways to Evaluate Their Role and Therapeutic Potential in MDD Symptomatic Domains
- Lindner Center of Hope, Mason
被験者募集中第1/2相
18歳〜60歳 · 全性別 · 2026/08/03更新 · NCT06795451A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Neuro-Behavioral Clinical Research, North Canton
被験者募集中第3相
18歳〜74歳 · 全性別 · 2026/08/03更新 · NCT06775379Developing Resilience and Anxiety Management Through the Arts
- Case Western Reserve University, Cleveland
被験者募集中
8歳〜17歳 · 全性別 · 2026/07/31更新 · NCT07033052A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
- Cleveland Clinic - Cleveland /ID# 276309, Cleveland
- CincyScience /ID# 226318, West Chester
被験者募集中第3相
10歳〜17歳 · 全性別 · 2026/07/27更新 · NCT04777357Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Avon Lake
被験者募集中第3相
18歳以上 · 全性別 · 2026/07/24更新 · NCT06966401A Mechanistic Study to Assess a Single Dose of CYB003 in Participants With Depression and Anxiety
- The Ohio State University Department of Psychiatry, Columbus
被験者募集中第2相
21歳〜65歳 · 全性別 · 2026/07/23更新 · NCT06820723Virtual Poetry Workshops to Enhance Patient Well Being and Reduce Anxiety
- Ohio State University Wexner Medical Center, Columbus
被験者募集中
18歳以上 · 全性別 · 2026/07/21更新 · NCT07717541TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age
- Cincinnati Children's Hospital Medical Center, Cincinnati
被験者募集中観察研究
18 Months – 11 Years · 全性別 · 2026/07/06更新 · NCT07048574A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
- The Ohio State University, Columbus
- Charak Center for Health and Wellness, Garfield Heights
被験者募集中
18歳以上 · 全性別 · 2026/06/15更新 · NCT03887715Teenthrive 2: Treatments for Improving Mood in Teens
- Nationwide Children's Hospital, Columbus
被験者募集中
12歳〜18歳 · 全性別 · 2026/06/10更新 · NCT07475845Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung Cancer
- Ohio State University Comprehensive Cancer Center, Columbus
被験者募集中第2相
18歳以上 · 全性別 · 2026/05/14更新 · NCT07216404A Precision Medicine Approach to Target Engagement for Emotion Regulation
- Ohio State University, Columbus
被験者募集中
18歳以上 · 全性別 · 2026/05/11更新 · NCT05651295A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- The Ohio State University, Columbus
- Neuro Behavioral Clinical Research, Inc., North Canton
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/05/11更新 · NCT06524830Virtual Patient Groups for Sarcoidosis Associated Fatigue
- Cleveland Clinic, Cleveland
被験者募集中
18歳以上 · 全性別 · 2026/04/24更新 · NCT07073963Positive Processes and Transition to Health - Single-Session (PATH-SS)
- Case Western Reserve University, Cleveland
被験者募集中参加者への支払いあり
18歳〜65歳 · 全性別 · 2026/04/22更新 · NCT06900712Prefrontal Glutamatergic Modulation by NAC and MBCT for Depression in Youth
- University of Cincinnati, Department of Psychiatry and Behavioral Neuroscience, Cincinnati
被験者募集中第3相
15歳〜24歳 · 全性別 · 2026/03/11更新 · NCT07464886Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus
- Cincinnati Children's Hospital Medical Center, Cincinnati
被験者募集中
12歳〜22歳 · 全性別 · 2025/10/30更新 · NCT06232304Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Avon Lake
被験者募集中第3相
18歳以上 · 全性別 · 2025/10/29更新 · NCT06786624Mechanisms of Rumination Change in Adolescent Depression
- Nationwide Children's Hospital, Columbus
- The Ohio State University, Columbus
被験者募集中
14歳〜17歳 · 全性別 · 2025/08/11更新 · NCT03859297A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
- Clinical Research Site, Cincinnati
被験者募集中第4相
18歳〜65歳 · 全性別 · 2025/01/23更新 · NCT06223880ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。